Snowball logo
logo
6827

MegaPro Biomedical Co., Ltd

6827 TWO
NT$10.00-NT$0.25  (2.44%)
Estimate
EPS
-1.81
Beta
0.265
About the company
Ticker
6827
ISIN
TW0006827009
Country
Taiwan
Sector (GICS)
Other
MegaPro Biomedical Co., Ltd, a biotech company, focuses on the development of nano drugs. It also develops MPB-1523, an IOP injection that is in Phase II clinical trial for use in the treatment of hepatocellular carcinoma; and MPB-1514, an iron injection that is in Phase II clinical trial for use in the treatment of iron deficiency anemia, as well as MPB-1734, an anti-cancer drug that is in preclinical trial for the treatment of malignant tumor. The company was founded in 2014 and is based in Zhubei, Taiwan.

Frequently asked questions

What sector does MegaPro Biomedical Co., Ltd (6827) operate in?

MegaPro Biomedical Co., Ltd belongs to the Other sector and operates in the Biotechnology industry.

What is MegaPro Biomedical Co., Ltd (6827) current stock price?

As of the latest data, MegaPro Biomedical Co., Ltd stock price is NT$10.00, with a previous close of NT$10.25. MegaPro Biomedical Co., Ltd lost -NT$0.25 in the last trading session, representing a -2.44% loss.

What is MegaPro Biomedical Co., Ltd (6827) current market capitalization?

MegaPro Biomedical Co., Ltd market cap is approximately 793.30 million.

What is MegaPro Biomedical Co., Ltd (6827) Earnings Per Share (EPS)?

The trailing EPS is -NT$1.81.

Does MegaPro Biomedical Co., Ltd (6827) pay dividends?

No. MegaPro Biomedical Co., Ltd does not pay a dividend.

What is MegaPro Biomedical Co., Ltd (6827) beta (volatility) score?

MegaPro Biomedical Co., Ltd has a beta of 0.265, indicating lower volatility than the overall market.